Skip to main navigation
Go to Cumberland Pharmaceuticals, Inc. homepage
  • About Us
    • Profile & Mission
    • Our Strategy
    • Board of Directors
    • Management Team
    • Company History
  • Our Products
    • Commercial Products
    • Pipeline Products
    • International Partners
  • Investor Relations
    • Overview
    • Corporate Update
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Stock Information
      • Historic Price Lookup
      • Ownership Profile
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Earnings Calls & Presentations
    • Investor FAQs
    • Press Releases
    • Contact Investor Relations
  • News
  • Cumberland Emerging Technologies
  • Blog
  • About Us
    • Profile & Mission
    • Our Strategy
    • Board of Directors
    • Management Team
    • Company History
  • Our Products
    • Commercial Products
    • Pipeline Products
    • International Partners
  • Investor Relations
    • Overview
    • Corporate Update
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Stock Information
      • Historic Price Lookup
      • Ownership Profile
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Earnings Calls & Presentations
    • Investor FAQs
    • Press Releases
    • Contact Investor Relations
  • News
  • Cumberland Emerging Technologies
  • Blog
Contact
Contact

Investor FAQs

Show All

Cumberland Pharmaceuticals is traded on the NASDAQ market under the symbol CPIX.

Cumberland Pharmaceuticals completed its initial public offering on August 14, 2009.

No, stock cannot be purchased directly from Cumberland Pharmaceuticals, but it can be purchased through a broker or trading service.

Information regarding the Company’s new release dates and other upcoming events can be found on our Earnings Calls and Presentations page.

Company information is available through this web site. You may sign up to receive email alerts or printed materials.

Cumberland Pharmaceuticals does not currently pay a dividend on its common stock.

January 1 - December 31

Toll Free Number for Cumberland Shareholders is: 800-509-5586

Shareholder Correspondence: 
Continental Stock Transfer & Trust Company
17 Battery Place
New York, NY 10004

Carr, Riggs, & Ingram, LLC, independent registered public accounting firm

© 2026 Cumberland Pharmaceuticals, Inc. All Rights Reserved.

Privacy Policy
Accessibility Statement
Terms of Use